For research use only
| Cat No. | ABC-X0054C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocyte |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The human cKIT (V559D_D820G) BAF3 cell line is an ideal model for researching GIST and hematologic malignancies, supporting compound screening.
Human cKIT (V559D_D820G) BAF3 Cell Line is a genetically engineered model derived from selected murine Ba/F3 parental cell line based on customers’ requirement. This dual mutant model is constructed by lentiviral integration of human cKIT gene harboring V559D and D820G mutations.
Target
cKIT is a receptor tyrosine kinase that regulates hematopoiesis, melanogenesis, and gametogenesis. The V559D mutation leads to constitutive activation in the juxtamembrane domain, while D820G, in the kinase domain, is associated with secondary resistance to cKIT inhibitors. This dual mutant enables in-depth analysis of cKIT signaling dysregulation and drug resistance. AcceGen supports generation of dual or complex mutation models to meet custom research needs. Polyclonal or monoclonal is optional.
| Species | Human |
| Cat.No | ABC-X0054C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocyte |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The cKIT (V559D_D820G) BAF3 Cell Line is ideal for studying oncogenic signaling, drug resistance mechanisms, and combination therapy testing in GIST and hematologic malignancies. It enables high-throughput compound screening and precision oncology development.